Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 12 studies | 29% ± 11% | |
oligodendrocyte | 6 studies | 24% ± 9% | |
astrocyte | 5 studies | 28% ± 9% | |
capillary endothelial cell | 4 studies | 21% ± 5% | |
adventitial cell | 4 studies | 26% ± 4% | |
Mueller cell | 3 studies | 17% ± 1% | |
endothelial cell of vascular tree | 3 studies | 34% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 96% | 17744.71 | 440 / 459 | 71% | 6.31 | 799 / 1118 |
brain | 59% | 3064.91 | 1555 / 2642 | 100% | 92.57 | 704 / 705 |
thymus | 65% | 3926.00 | 422 / 653 | 68% | 3.74 | 413 / 605 |
esophagus | 67% | 5822.54 | 965 / 1445 | 43% | 2.60 | 78 / 183 |
kidney | 37% | 1470.30 | 33 / 89 | 66% | 11.89 | 593 / 901 |
adipose | 100% | 25168.11 | 1201 / 1204 | 0% | 0 | 0 / 0 |
skin | 76% | 7937.97 | 1373 / 1809 | 21% | 1.32 | 98 / 472 |
intestine | 66% | 4209.79 | 641 / 966 | 21% | 1.26 | 111 / 527 |
blood vessel | 86% | 10302.75 | 1142 / 1335 | 0% | 0 | 0 / 0 |
bladder | 62% | 6302.38 | 13 / 21 | 22% | 1.38 | 113 / 504 |
ovary | 63% | 4098.67 | 114 / 180 | 16% | 0.70 | 67 / 430 |
lung | 39% | 1695.06 | 227 / 578 | 37% | 1.83 | 433 / 1155 |
uterus | 56% | 2548.73 | 96 / 170 | 18% | 2.48 | 84 / 459 |
stomach | 42% | 2381.79 | 152 / 359 | 31% | 1.64 | 89 / 286 |
adrenal gland | 11% | 288.07 | 29 / 258 | 57% | 4.02 | 131 / 230 |
muscle | 66% | 4330.73 | 526 / 803 | 0% | 0 | 0 / 0 |
pancreas | 2% | 51.61 | 7 / 328 | 59% | 3.68 | 105 / 178 |
spleen | 52% | 1526.70 | 125 / 241 | 0% | 0 | 0 / 0 |
heart | 42% | 1805.87 | 363 / 861 | 0% | 0 | 0 / 0 |
prostate | 21% | 847.44 | 51 / 245 | 12% | 0.38 | 62 / 502 |
liver | 0% | 0 | 0 / 226 | 24% | 0.97 | 98 / 406 |
tonsil | 0% | 0 | 0 / 0 | 20% | 1.33 | 9 / 45 |
eye | 0% | 0 | 0 / 0 | 9% | 0.54 | 7 / 80 |
peripheral blood | 0% | 10.99 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016266 | Biological process | O-glycan processing |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0030133 | Cellular component | transport vesicle |
GO_0004653 | Molecular function | polypeptide N-acetylgalactosaminyltransferase activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | GALNT15 |
Protein name | Polypeptide N-acetylgalactosaminyltransferase 15 Testis tissue sperm-binding protein Li 61n (UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15) (UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5, isoform CRA_c) Polypeptide N-acetylgalactosaminyltransferase (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase) Polypeptide N-acetylgalactosaminyltransferase 15 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 2) (GalNAc-T-like protein 2) (pp-GaNTase-like protein 2) (Polypeptide N-acetylgalactosaminyltransferase-like protein 2) (Protein-UDP acetylgalactosaminyltransferase-like protein 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2) |
Synonyms | GALNTL5 GALNTL2 tcag7.1273 hCG_1990635 UNQ770/PRO1564 |
Description | FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Although it displays a much weaker activity toward all substrates tested compared to GALNT2, it is able to transfer up to seven GalNAc residues to the Muc5AC peptide, suggesting that it can fill vicinal Thr/Ser residues in cooperation with other GALNT proteins. Prefers Muc1a as substrate. . |
Accessions | A0A090N7Y5 A0A3B3IRY6 C9JGI4 Q68VI9 ENST00000339732.10 ENST00000437509.3 ENST00000650034.1 Q8N3T1 |